Thrombin Market to Exhibit CAGR of 4.1% Despite Limited Product Innovations | Fortune Business Insights

The Global Thrombin Market was valued at US$ 535.0 Mn and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025. . Thrombin inhibitors play a major part in delaying blood clotting.

Pune, India - May 16, 2019 /MarketersMedia/ —

The Global Thrombin Market is favored by the rising incidence of thrombosis among people, globally. The fatal nature of thrombosis and use of thrombin to trump thrombosis is emphasized in Fortune Business Insights’ latest report, titled “Thrombin Market: Global Analysis, Insights and Forecasts, 2019-2026.” In the report, Fortune Business Insights has briefed that an increasing emphasis on clinical trials of thrombin has boosted the global market and it is estimated to expand at a CAGR of 4.1%. As of 2018, the global thrombin market was valued at US$ 535.0 Mn and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025.

Thrombosis can be caused due to mere sedentary lifestyle habits such as smoking and some other factors such as heart failures, aging, and cancer. Thrombin inhibitors play a major part in delaying blood clotting. The healing properties of thrombin, along with its ability to minimize bleeding during surgical procedures has led to an increase in demand for thrombin over the years.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/thrombin-market-100170

Widespread Applications of Thrombin to Boost Global Market

Thrombin has come a long way from its conventional use to stop bleeding in small cuts on body parts. Now, thrombin plays a major role in most of the surgeries, worldwide. The clinical efficiency of thrombin has led to its widespread use in the healthcare industry, a key factor enabling growth in the global thrombin market. Thrombin is vastly effective in facilitating surgical hemostasis. Over the years, human thrombin was replaced with bovine thrombin, due to its increased efficiency in surgical procedures.

Bovine-derived thrombin was successfully used in patients with hemodialysis. Bovine thrombin is massively helpful in treating hemorrhages in hemodialysis, wherein an excessive amount of blood is lost. The extent of blood losses in hemodialysis can lead to various disorders and may also prove fatal in some cases. Thus, bovine-derived thrombin is given huge emphasis and healthcare professionals have prioritized thrombin for treating hemorrhages. The thrombin market is therefore forecast to witness a high demand for bovine-derived thrombin in the com9ing years.

Recothrom to Emerge as The Most Widely Used Product Type

As surgical blood loss has been prioritized by surgeons and healthcare professionals worldwide, there is an increasing need for an efficient solution to minimize such severe losses. Recothrom was initially manufactured by a US-based company, ZymoGenetics. After involvement from Bayer Healthcare, Recothrom was later acquired by Baxter International. The 2018 acquisition of Recothrom by Baxter has proved fruitful to the overall market. As of now, Recothrom is the only drug that has been clinically approved for commercial use as a recombinant thrombin brand. Furthermore, Recothrom finds applications in cases where standard surgical procedures such as suture or cautery are ineffective.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/thrombin-market-100170

Besides Baxter, there have been significant activities from other companies that have contributed to the growth of the global thrombin market. Attractive business strategies of companies such as Pfizer have had a positive impact on the overall market. Pfizer’s has emerged as the leading company, backed by high clinical efficiency of its product ‘Thrombin JMI’. Some other companies that are operating in the global thrombin market are Johnson & Johnson Services Inc., Shanghai RAAS Blood Products Co. Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co.

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: +1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/thrombin-market-to-exhibit-cagr-of-41-despite-limited-product-innovations-fortune-business-insights/513505

Source: MarketersMedia

Release ID: 513505

Latest News

1st test: England 76-2 at lunch v Australia; Roy, Root out

Aug 18, 2019

LONDON — Josh Hazlewood took two early wickets, including the key one of Joe Root, on his return to the Australia team before England fought back to reach lunch at 76-2 as the second Ashes test finally got underway Thursday. The paceman got an edge behind by Jason Roy for 0 off the third ball of his first over and then trapped Root, England's captain and best batsman, lbw for 14. Hazlewood had figures of 2-14 off 10 overs at Lord's after coming into Australia's attack to replace James Pattinson. Reeling at 26-2, England got through the rest of Day...

England wins 33-19 to stop Wales going top of rankings

Aug 18, 2019

LONDON — England ended Wales' 14-match winning run with a comprehensive 33-19 victory at Twickenham on Sunday in a World Cup warmup game and prevented the visitors from replacing New Zealand at the top of the rugby rankings. Warren Gatland's strongest available Wales team included 13 starters from the Grand Slam-clinching victory over Ireland in March. England began its World Cup preparations with an experimental team which established a healthy 24-7 lead through tries by Billy Vunipola, Joe Cokanasiga and Luke Cowan-Dickie, and went on to survive touchdowns from George North and Wyn Jones. George Ford, England captain in the...

Two-goal Kane leads Tottenham to 3-1 comeback win over Villa

Aug 18, 2019

LONDON — Harry Kane scored two late goals as Tottenham came from behind to start its Premier League campaign with a 3-1 win over promoted Aston Villa on Saturday. Tanguy Ndombele also struck on his debut as Mauricio Pochettino's side dug deep to overcome a stubborn Villa team. Kane, who missed a good chance in first-half injury time, capitalized on a defensive lapse from Jack Grealish before coolly slotting the ball past goalkeeper Tom Heaton in the 86th minute. The England forward then grabbed his second in the 90th after being set up by Moussa Sissoko. It was just reward...

Klopp putting faith in Brewster in bid to end title wait

Aug 18, 2019

LIVERPOOL, England — If Rhian Brewster lives up to the hype, he will have saved Liverpool manager Jürgen Klopp millions in the transfer window. The 19-year-old is set for his breakthrough season with the first team after being lined up for more than a year to fill the boots of departed striker Daniel Sturridge. While the England Under-17 World Cup winner will start as backup to Roberto Firmino and Champions League hero Divock Origi, the promise he has shown already suggests he could have a part to play in Liverpool's bid to end a 30-year wait for the Premier League...

Australia wins 1st Ashes test by 251 runs, Lyon takes 6-49

Aug 18, 2019

BIRMINGHAM, England — Australia won the first Ashes test by a huge margin of 251 runs on Monday after dismissing England for 146 in its second innings on the final day. Offspinner Nathan Lyon was often unplayable with 6-49 and passed 350 test wickets in a remarkable turnaround for the Australians who had been reduced to 122-8 in their first innings at a hostile Edgbaston. "It's disappointing, we got ourselves in a really strong position," England captain Joe Root told the BBC. Allrounder Chris Woakes provided England's top score with a defiant 37 at No. 9 after the hosts crumbled...

About Us

Daily Sports Global, your guide to the best sports news on the Internet. Access to the world’s biggest sports events right here even if you’re not physically there.

Contact us: sales[at]dailysportsglobal.com

Subscribe Now!